Objective Access to Pharmaceuticals Equitable access to pharmaceuticals, particularly for developing countries is an essential human right. Various complex impediments hinder access, which is the subject of ongoing multidisciplinary studies. Intellectual Property and product development are two issues that can be used as tools to address the problem of access, particularly to make patented drugs more affordable and accessible. This proposal addresses three ways of accomplishing this. The first is how academic licensing practices under socially responsible stewardship can ensure that future drugs that have resulted from inventive activity in academia will be available at low cost with improved access in the future. Secondly we will research thoroughly how existing public-private or product-development partnerships are addressing the issue of altruistic development of drugs for relatively neglected populations with unmet health needs and the lessons they have for future drug development. Lastly it addresses the current state and future improvements in compulsory licensing legislative instruments to enable access through generic manufacture of patented drugs. The three routes to access have several significant aspects of overlap which provide for complementary approaches and solutions to access. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs Programme(s) FP7-HEALTH - Specific Programme "Cooperation": Health Topic(s) HEALTH-2009-4.3.2-2 - Access to medicines (SICA) Call for proposal FP7-HEALTH-2009-single-stage See other projects for this call Funding Scheme CP-FP-SICA - Small/medium-scale focused research project for specific cooperation actions dedicated to international cooperation partner countries(SICA) Coordinator ST GEORGE'S HOSPITAL MEDICAL SCHOOL EU contribution € 469 942,40 Address CRANMER TERRACE SW17 0RE London United Kingdom See on map Region London Inner London — West Wandsworth Activity type Higher or Secondary Education Establishments Administrative Contact Paul Craven (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Participants (4) Sort alphabetically Sort by EU Contribution Expand all Collapse all UNIVERSITE DE NEUCHATEL Switzerland EU contribution € 404 299,60 Address FAUBOURG DE L'HOPITAL 41 2000 NEUCHATEL See on map Region Schweiz/Suisse/Svizzera Espace Mittelland Neuchâtel Activity type Higher or Secondary Education Establishments Administrative Contact Daniel Kraus (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data SOUTH AFRICAN MEDICAL RESEARCH COUNCIL South Africa EU contribution € 366 532,00 Address Francie van Zijl Drive - Parowvalley 7505 Tygerberg See on map Activity type Research Organisations Administrative Contact Philip Du Plessis (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data INTERNATIONAL VACCINE INSTITUTE South Korea EU contribution € 160 000,00 Address San 4-8 Bongcheon-7 dong, Kwanak gu 151919 Seoul See on map Activity type Research Organisations Administrative Contact Richard Mahoney (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data FUNDACAO OSWALDO CRUZ Brazil EU contribution € 354 000,00 Address AVENIDA BRASIL 4365 21040 900 Rio De Janeiro See on map Activity type Research Organisations Administrative Contact Carlos Medicis Morel (Prof.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data